Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023

BUY
$211.93 - $241.33 $352,439 - $401,331
1,663 New
1,663 $401,000
Q4 2022

Jan 24, 2023

BUY
$203.72 - $248.97 $6.93 Million - $8.46 Million
34,000 New
34,000 $8.01 Million
Q4 2021

Feb 11, 2022

SELL
$271.6 - $314.21 $2.66 Million - $3.08 Million
-9,800 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$274.82 - $308.34 $3.35 Million - $3.76 Million
-12,200 Reduced 55.45%
9,800 $2.76 Million
Q1 2021

May 11, 2021

BUY
$204.88 - $255.03 $1.13 Million - $1.4 Million
5,500 Added 33.33%
22,000 $5.61 Million
Q4 2020

Feb 11, 2021

SELL
$186.91 - $214.42 $859,786 - $986,332
-4,600 Reduced 21.8%
16,500 $3.36 Million
Q3 2020

Nov 13, 2020

SELL
$167.03 - $201.3 $1.49 Million - $1.79 Million
-8,900 Reduced 29.67%
21,100 $3.97 Million
Q2 2020

Aug 13, 2020

BUY
$113.31 - $182.44 $3.4 Million - $5.47 Million
30,000 New
30,000 $4.98 Million
Q1 2020

May 12, 2020

SELL
$104.32 - $195.28 $5.99 Million - $11.2 Million
-57,400 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$163.48 - $173.61 $9.38 Million - $9.97 Million
57,400 New
57,400 $9.71 Million
Q2 2019

Aug 13, 2019

SELL
$144.16 - $172.9 $8.79 Million - $10.5 Million
-61,000 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$123.7 - $156.3 $7.55 Million - $9.53 Million
61,000 New
61,000 $9.33 Million
Q4 2018

Feb 14, 2019

SELL
$120.82 - $174.09 $333,704 - $480,836
-2,762 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$167.67 - $188.27 $443,822 - $498,350
2,647 Added 2301.74%
2,762 $480,000
Q2 2018

Aug 01, 2018

BUY
$160.33 - $189.41 $18,437 - $21,782
115 New
115 $21,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Mufg Securities Emea PLC Portfolio

Follow Mufg Securities Emea PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Securities Emea PLC, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Securities Emea PLC with notifications on news.